According to Ovum practice leader, Nicole Engelbert, pharmaceutical companies are increasing the number of trials conducted in the region partly due to economic factors but also because of specific regulatory requirements tying the commercialisation of novel drugs to domestic clinical trials.
"The public are increasingly questioning the safety of new drugs, driving more thorough clinical trials, which in turn is escalating the demand for solutions to manage the process more effectively and efficiently,' Engelbert says.
'Electronic data capture (EDC) systems are crucial to managing this data efficiently, but uptake has remained low, after being hampered by the recession. However, this is changing and companies are back on track and are once again eager to implement EDC systems. We therefore expect a spike in investment in new systems over the next couple of years.'
Ovum's report provides life sciences companies with analysis of the EDC vendors it recommends they should consider, and the analyst firm says that overall, the solutions that are available today are a vast improvement on systems offered in the past, which it were often poorly designed.
'The key to a good solution is that it is a web-based or software-as-a-service offering that takes into consideration clinical research workflows, using intuitive interfaces and the most up-to-date technology,' Engelbert says.
'While many EDC solutions have evolved to become more user-friendly, many vendors are selling a technology that is old and no longer sustainable. While vendors in this evaluation generally scored highly for usability and flexibility, they need to continue to improve the interfaces of their systems.'
The report also notes that as the e-clinical technology market matures, a good EDC system will be only one part of a wider, connected, e-clinical platform, rather than a stand-alone solution.
'This will allow solutions to share data seamlessly and reduce redundancy in data, decreasing some of the inaccuracies caused by inputting the same data in multiple systems,' Engelbert concludes.